शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSECentuple Global Ltd· Pharmaceuticals & BiotechnologyHighNegative
Announced Wed, 18 Mar, 2026 · 17:05 IST

Outcome of Board Meeting

Multiple Ind Directors ResignedManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+5.0%Reaction day
₹49.68
prior close
₹52.16
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-2.8%+7.8% vs market
Pharmaceuticals peers, median of 156sector-1.8%+6.8% vs sector

On the reaction day the stock moved 7.8 pts more than Nifty Microcap 250 and 6.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+5.0-2.8+7.8-1.8+6.8
Next day
+10.1-2.0+12.1-1.0+11.1
2d
+4.7-6.5+11.2-4.9+9.6
3d
-0.5-3.8+3.3-3.2+2.7
4d
-5.2-1.5-3.7-1.8-3.3
5d
-9.9-4.3-5.6-4.3-5.6
1w
-4.8-2.8-2.0-3.5-1.3
15d
+12.0+8.2+3.9+6.9+5.1
1m
+28.5+10.1+18.4+6.5+22.0
2m
-13.4+12.4-25.9+9.5-23.0
3m
-20.5+23.5-44.0+13.9-34.4
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Centuple Global Ltd held a board meeting on March 18, 2026, where two Non-Executive Independent Directors — Ms. Bhawna Saunkhiya and Mr. Saurabh — resigned, both citing pre-occupation and personal commitments. The board confirmed there are no other material reasons behind their resignations. To fill the vacancies, two new Additional Non-Executive Independent Directors were appointed: Mr. Ashish Jain, a Chartered Accountant, and Mr. Gaurav Kaushik, a Company Secretary, both for a 5-year term subject to shareholder approval. Neither new director is related to existing directors, promoters, or holds any shares in the company.

Likely market impact

The simultaneous exit of two independent directors and quick replacement suggests routine board reshuffling rather than any governance concern, which should keep shareholder sentiment neutral. The new appointees bring strong financial and compliance expertise, which may strengthen board oversight.